Utilización hospitalaria de levofloxacino

Castells, X; Vallano, A; Campany, D; Rigau, D; Arnau, J. M.
Rev. esp. quimioter ; 16(2): 221-226, jun. 2003.
Artículo en Es | IBECS (España) | ID: ibc-27502

Documentos relacionados

  1. Vacancy-Rich CoS<sub><i>x</i></sub>@LDH@Co-NC Catalytic Membrane for Antibiotic Degradation with Mechanistic Insights.
  2. Responses of cyanobacterium Microcystis aeruginosa under single and repeated ofloxacin exposure.
  3. Removal of ofloxacin using a porous carbon microfiltration membrane based on in-situ generated •OH.
  4. Levofloxacin pharmacokinetics and tissue residue concentrations after oral administration in Bilgorajska geese.
  5. Unique Physiological and Genetic Features of Ofloxacin-Resistant <i>Streptomyces</i> Mutants.
  6. Study effect and mechanism of ofloxacin and levofloxacin on development of Rana nigromaculata tadpoles based on the hypothalamus-pituitary-thyroid axis.
  7. Hydrothermal Synthesis of Cadmium Sulfide Photocatalyst for Detoxification of Azo Dyes and Ofloxacin Antibiotic in Wastewater.
  8. The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis.
  9. Validated spectrofluorimetric assay of two co-administered drug mixtures containing hydroxychloroquine with either moxifloxacin or ofloxacin as a drug regimen for hospital-acquired pneumonia in patients with COVID-19.
  10. Evaluation of kasugamycin as a chiral selector in capillary electrophoresis.